This Article Full Text Full Text (PDF) All Versions of this Article: 35/6/1333    most recent 01.STR.0000128418.17312.0ev1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Møller, K. Articles by Larsen, F. S. Search for Related Content PubMed PubMed Citation Articles by Møller, K. Articles by Larsen, F. S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB EPINEPHRINE PROPOFOL Related Collections Other Treatment Brain Circulation and Metabolism

(Stroke. 2004;35:1333.)
© 2004 American Heart Association, Inc.

Original Contributions

Cerebral Blood Flow and Metabolism During Infusion of Norepinephrine and Propofol in Patients With Bacterial Meningitis

Kirsten Møller, MD, PhD; Tavs Qvist, MD; Flemming Tofteng, MD; Christian Sahl, MD; Signe Sønderkær, MD; Thomas Dethloff, MD; Gitte Moos Knudsen, MD, DMSc Fin Stolze Larsen, MD, PhD, DMSc

From the Departments of Infectious Diseases (K.M., T.Q., S.S.), Hepatology (F.T., T.D., F.S.L.), Intensive Care (C.S.), and Neurology (G.M.K.), University Hospital Rigshospitalet, Copenhagen, Denmark.

Correspondence to Kirsten Møller, Department of Infectious Diseases, M5132, University Hospital Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen Ø, Denmark. E-mail kirsten.moller{at}dadlnet.dk

Background and Purpose— In patients with severe bacterial meningitis, norepinephrine is often infused to increase mean arterial pressure (MAP). This increases cerebral blood flow (CBF), but it is unknown if this increase is caused by impaired cerebral autoregulation or by a cerebral effect of norepinephrine through increased cerebral metabolism. The latter possibility implies a CBF–metabolism coupling. This has not been studied during meningitis. We studied the effect of norepinephrine and propofol on CBF and oxidative metabolism in patients with severe bacterial meningitis.

Methods— In seven patients with pneumococcal meningitis and 7 healthy subjects, norepinephrine was infused intravenously; patients also underwent intravenous propofol infusion. Global CBF was measured by the Kety–Schmidt technique; cerebral oxidative metabolism and net flux of norepinephrine and epinephrine were calculated from measured arterial-to-jugular venous concentration differences (a-vD).

Results— During norepinephrine infusion, MAP increased from a median value of 79 (range, 70 to 89) to 99 (98 to 129) mm Hg in patients, and from 87 (72 to 103) to 123 (112 to 132) mm Hg in controls. CBF increased in patients (51 [48 to 60] to 59 [54 to 77] mL/100 g per minute) but remained unchanged in controls. The cerebral metabolic rate of oxygen (CMRO₂) decreased in patients and remained unchanged in controls. No cerebral net flux of norepinephrine or epinephrine was found at any time in the 2 groups. During propofol infusion, CMRO₂, and the a-vDO₂ decreased whereas CBF was unchanged.

Conclusions— In patients with severe bacterial meningitis, norepinephrine increases both MAP and CBF but not CMRO₂, indicating impaired autoregulation. Propofol reduces CBF relatively less than cerebral metabolism, suggesting a resetting of the CBF–CMRO₂ relationship.

Key Words: energy metabolism • meningitis • blood flow

This article has been cited by other articles:

				M. Pedersen, C. T. Brandt, G. M. Knudsen, C. Ostergaard, P. Skinhoj, N. Frimodt-Moller, and K. Moller Cerebral blood flow autoregulation in early experimental S. pneumoniae meningitis J Appl Physiol, January 1, 2007; 102(1): 72 - 78. [Abstract] [Full Text] [PDF]